About this event
In our first mdwebinar of 2023, we’ll examine the impact of decentralisation in clinical trials from the site, patient and sponsor’s perspective. Our host, LaQuinta Jernigan, is joined by:
This is a unique opportunity to explore the future of clinical research from all angles and hear from some of the most influential voices in clinical trials today.
If you have any accessibility requirements you would like to make us aware of before the event, please contact our webinar organiser email@example.com
We facilitate remarkable patient experiences at every stage of the clinical journey. Powered by next-generation care management tools and technologies, our solutions focus on the four key metrics of a successful clinical trial: recruitment, engagement, retention and trial outcomes.
As the Deputy to our Chief Operating Officer, and head of our North America territory, LaQuinta brings a wealth of healthcare knowledge and expertise in building sustainable, strong commercial relationships. By listening carefully to each client’s challenges, concerns and goals, LaQuinta works with them to find effective solutions. With a life sciences career spanning operations and sales, she has a balanced perspective: she knows what it takes to bring a product to market on time, retain patients and do so within budget, while putting the patient at the heart of what we do. Enthusiastic and energetic, LaQuinta is motivated by a desire to improve the patient experience by removing any challenge that could impact their quality of life during a clinical trial. For her, being part of mdgroup is about more than selling a service: it’s about focusing on lasting and productive partnerships that always put the patient first.
Megan started in the industry in 1997 as a Research Coordinator in Detroit MI working with people living with HIV/AIDS and enrolling them in NIH sponsored clinical trials. Relocated to RTP where she took the pathway of CRA, Clinical Team Lead, and Project Management on both the CRO and Pharma side. Roles throughout her career have been primarily in the project management and/or oversight of clinical trials - this includes not only leading cross-functional project teams including vendors, financial management, and issue escalation but also supporting and costing proposals, defining the operational strategy needed to successfully execute a clinical trial, and selecting and vetting vendor services. Currently, Megan is Vice President of Clinical Operations at ProKidney, a biotech developing an autologous cell therapy for patients with Chronic Kidney Disease.
Christine Daniels, PhD is originally from Atlanta, Georgia. She has more than 10 years of lab research experience in areas including: gene therapy, cancer biology and vaccine development. Dr. Daniels completed a postdoctoral fellowship at Duke University’s Human Vaccine Institute where her research focused on the development of novel HIV vaccine candidates using nanoparticles as a delivery platform. Currently, Dr. Daniels works as a scientist at a biopharmaceutical company focused on developing gene therapies for rare diseases. Additionally, Dr. Daniels is a board member for the Gregory B. Davis Foundation and is involved in multiple outside projects that aim to improve vaccine literacy and encourage underrepresented minorities to pursue higher education and careers in STEM fields.
Jameka Hill is the Senior Director, Clinical Trial Health Equity at Moderna. Within this role she is leading patient advocacy and clinical trial diversity efforts to deepen patient advocacy and community health partnerships with organizations working to meet the needs of medically underserved populations, while also embedding into Moderna’s operating model patient-focused initiatives and processes that ensure historically underrepresented groups and vulnerable populations are included in the drug development process and represented in Moderna clinical trials. For over 20 years, Jameka has focused exclusively on improving access to clinical trials as a care option for women, older adults, racial and ethnic minority groups, patients living with rare diseases, and vulnerable populations including pregnant women and pediatrics. Jameka is an avid health literacy and community engagement advocate who strongly believes in the importance of collaborating with internal stakeholders and ex...
Eric South is Founder and President of Gladiator Project, a 501(c)(3) public charity focused on supporting patients and funding research to find a cure for Glioblastoma Multiforme (GBM). Eric has over 15 years of information technology consulting and staffing experience, currently serving as Regional Vice President for Robert Half. Eric has been interviewed and his story shared through various media outlets such as Today.com, Apple News, MSN.com, The Tennessean, and WSMV, promoting the philanthropic work Eric and his wife Leslie are doing through Gladiator Project. Eric is involved in patient advocacy around clinical trials and patient support. Eric was interviewed for a podcast by mdgroup, a London, England based patient advocacy organization and also served as a panelist for the North Carolina Biosciences Organization (NCBIO) Clinical Trials Forum. Eric is also involved in the tech community, having previously served as the President of the Tennessee chapter of the Internation...
We facilitate remarkable patient experiences at every stage of the clinical journey.